Regulus Therapeutics Inc. Insider Trading for July 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Regulus Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Regulus Therapeutics Inc. for July 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 25 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.55 | 1,700 | 11,137 | 7,010,800 | 7 M to 7 M (-0.02 %) |
| Jul 25 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.81 | 1,850 | 12,598 | 7,012,500 | 7 M to 7 M (-0.03 %) |
| Jul 25 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.88 | 1,700 | 11,702 | 7,014,350 | 7 M to 7 M (-0.02 %) |
| Jul 25 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.55 | 1,700 | 11,137 | 6,111,800 | 6.1 M to 6.1 M (-0.03 %) |
| Jul 25 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.81 | 1,850 | 12,598 | 6,113,500 | 6.1 M to 6.1 M (-0.03 %) |
| Jul 25 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.88 | 1,700 | 11,702 | 6,115,350 | 6.1 M to 6.1 M (-0.03 %) |
| Jul 18 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.80 | 5,000 | 34,001 | 7,016,050 | 7 M to 7 M (-0.07 %) |
| Jul 18 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.58 | 5,000 | 32,906 | 7,021,050 | 7 M to 7 M (-0.07 %) |
| Jul 18 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.59 | 3,500 | 23,058 | 7,026,050 | 7 M to 7 M (-0.05 %) |
| Jul 18 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.80 | 5,000 | 34,001 | 6,117,050 | 6.1 M to 6.1 M (-0.08 %) |
| Jul 18 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.58 | 5,000 | 32,906 | 6,122,050 | 6.1 M to 6.1 M (-0.08 %) |
| Jul 18 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.59 | 3,500 | 23,058 | 6,127,050 | 6.1 M to 6.1 M (-0.06 %) |
| Jul 11 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.48 | 1,750 | 11,339 | 7,029,550 | 7 M to 7 M (-0.02 %) |
| Jul 11 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.69 | 4,500 | 30,109 | 7,031,300 | 7 M to 7 M (-0.06 %) |
| Jul 11 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 7.08 | 1,800 | 12,748 | 7,035,800 | 7 M to 7 M (-0.03 %) |
| Jul 11 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.48 | 1,750 | 11,339 | 6,130,550 | 6.1 M to 6.1 M (-0.03 %) |
| Jul 11 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.69 | 4,500 | 30,109 | 6,132,300 | 6.1 M to 6.1 M (-0.07 %) |
| Jul 11 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.08 | 1,800 | 12,748 | 6,136,800 | 6.1 M to 6.1 M (-0.03 %) |
| Jul 07 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 8.07 | 1,200 | 9,678 | 6,138,600 | 6.1 M to 6.1 M (-0.02 %) |
| Jul 07 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 8.07 | 3,100 | 25,011 | 6,139,800 | 6.1 M to 6.1 M (-0.05 %) |
| Jul 07 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | 10% Owner | Sell | S | 8.07 | 1,200 | 9,678 | 7,037,600 | 7 M to 7 M (-0.02 %) |
| Jul 07 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | 10% Owner | Sell | S | 8.07 | 3,100 | 25,011 | 7,038,800 | 7 M to 7 M (-0.04 %) |
| Jul 02 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 1.74 | 2,500 | 4,350 | 124,000 | |
| Jul 02 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 8.10 | 2,500 | 20,260 | 80,000 | 82.5 K to 80 K (-3.03 %) |
| Jul 02 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 1.74 | 2,500 | 4,350 | 82,500 | 80 K to 82.5 K (+3.13 %) |
| Jul 02 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President & CEO | Option Exercise | M | 0.38 | 3,505 | 1,332 | 462,307 | |
| Jul 02 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President & CEO | Sell | S | 8.11 | 3,505 | 28,426 | 0 | 3.5 K to 0 (-100.00 %) |
| Jul 02 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President & CEO | Buy | M | 0.38 | 3,505 | 1,332 | 3,505 | 0 to 3.5 K |